PCAR-019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCAR-019, covering 2016-08-01 to 2016-08-01. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma [Phase 1, Phase 2]